TotalMarketCap

Cryoport

CYRXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$813.425 M

$16.06 -3.83%

Close of 6 Nov 2026

As of 6 Nov 2026, Cryoport (CYRX) has a market capitalization of $813.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$176.2M

#2315 by revenue

Earnings

$78.3M

#1393 by earnings

Shares outstanding

50,700,429

Latest filing cover page

P/E ratio

10.4

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #158Aktis OncologyAKTS$820.9M
  2. #159Collegium PharmaceuticalCOLL$816.5M
  3. #160CryoportCYRX$813.4M
  4. #161AlumisALMS$756.5M
  5. #162AnnexonANNX$755.5M

What if Cryoport were worth as much as…

Open the what-if tool →

Gold $28.2T

$557,500.01

Per share 34,714× higher

Bitcoin $1.53T

$30,165.35

Per share 1,878× higher

Apple $5.02T

$99,030.04

Per share 6,166× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Cryoport are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.